Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × ruxolitinib × Clear all

Sponsor

Conditions

Primary Myelofibrosis 15 Myeloproliferative Disorders 13 Polycythemia Vera 8 Breast Neoplasms 6 Leukemia, Myeloid, Acute 5 Leukemia 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Hematologic Diseases 4 Myelodysplastic Syndromes 3 Bone Marrow Diseases 3 Thrombocytosis 2 Thrombocythemia, Essential 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Graft vs Host Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia-Lymphoma, Adult T-Cell 1

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡